Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women.
Ma W, Wang M, Wang K, Cao Y, Hertzmark E, Ogino S, Ng K, Willett WC, Giovannucci EL, Song M, Chan AT.
JAMA Oncol. 2022 May 05. PMID: 35511155
Professor of Pathology
Pathology-Brigham and Women's Hospital
Harvard Medical School
Dr. Ogino is Chief, Program in MPE Molecular Pathological Epidemiology of Department of Pathology, Brigham and Women's Hospital, developing the integrative interdisciplinary science of "Molecular Pathological Epidemiology (MPE)". He is an associate member of Broad Institute of MIT and Harvard. He has been serving as Chairperson for The International MPE Meeting Series since 2013. The 4th International Molecular Pathological Epidemiology (MPE) Meeting is planned to be held on May 31 to June 1, 2018 in Boston, MA, USA.
Dr. Ogino's research has a broad theme: Integration of Molecular Pathology, Omics (Genomics), Epidemiology, Bioinformatics, and Population Health Science. Dr. Ogino's focus is to develop new scientific disciplines, and develop new data analysis framework and methodologies. The Ogino Lab uses gastrointestinal cancers as model human diseases (including colorectal carcinoma, colorectal polyp, colorectal adenoma, pancreatic adenocarcinoma, neuroendocrine tumor, pancreatic endocrine tumor, carcinoid tumour). We have been analyzing germline and somatic genomics, transcriptomics, epigenomics, and immunomics in human tumors. Using massively parallel sequencing (next generation sequencing) technologies, the Ogino Lab has sequenced whole exome of over 1,000 colorectal carcinomas with high dimensional annotations, and calculated tumor neoantigen load. In addition, the Ogino Lab has obtained data on transcriptome of over 250 colorectal carcinomas (by RNA sequencing).
Dr. Ogino has created a number of new research frameworks, concepts, paradigms, and models, including molecular pathological epidemiology (MPE), the GWAS-MPE approach, the colorectal continuum model, the etiologic field effect model, the causal inference-MPE integration, lifecourse-MPE approach, social MPE, immuno-MPE (immunology-MPE integration), pharmaco-MPE, microbiology-MPE integration, MPE-comparative effectiveness research integration, and nutritional MPE.
AMP Executive Officer's Award
Association for Molecular Pathology (AMP)
USCAP Ramzi Cotran Young Investigator Award
United States and Canadian Academy of Pathology (USCAP)
AMP Meritorious Service Award
Association for Molecular Pathology (AMP)
Most Influential Scientific Minds
Thomson Reuters
ASCI Elected Member
American Society for Clinical Investigation (ASCI)
Member, FASEB Excellence in Science Award Committee
Federation of American Societies of Experimental Biology (FASEB)
Most Influential Scientific Minds
Thomson Reuters
NCI R35 Outstanding Investigator Award (OIA)
National Institute of Health (NIH)
Highly Cited Researcher
Thomson Reuters
Highly Cited Researcher
Clarivate Analytics
ASIP Outstanding Investigator Award
American Society for Investigative Pathology (ASIP)
Highly Cited Researcher
Clarivate Analytics
Runner-up for the Mentor-of-the-Year Award
Dana-Farber Cancer Institute
Invited Nominator for Nobel Prize in Physiology or Medicine 2019, 2020, 2021
Nobel Committee
Highly Cited Researcher 2019, 2020, 2021
Clarivate Analytics
Ma W, Wang M, Wang K, Cao Y, Hertzmark E, Ogino S, Ng K, Willett WC, Giovannucci EL, Song M, Chan AT.
JAMA Oncol. 2022 May 05. PMID: 35511155
Tian Y, Kim AE, Bien SA, Lin Y, Qu C, Harrison T, Carreras-Torres R, Díez-Obrero V, Dimou N, Drew DA, Hidaka A, Huyghe JR, Jordahl KM, Morrison J, Murphy N, Obón-Santacana M, Ulrich CM, Ose J, Peoples AR, Ruiz-Narvaez EA, Shcherbina A, Stern M, Su YR, van Duijnhoven FJB, Arndt V, Baurley J, Berndt SI, Bishop DT, Brenner H, Buchanan DD, Chan AT, Figueiredo JC, Gallinger S, Gruber SB, Harlid S, Hoffmeister M, Jenkins MA, Joshi AD, Keku TO, Larsson SC, Le Marchand L, Li L, Giles GG, Milne RL, Nan H, Nassir R, Ogino S, Budiarto A, Platz EA, Potter JD, Prentice RL, Rennert G, Sakoda LC, Schoen RE, Slattery ML, Thibodeau SN, Van Guelpen B, Visvanathan K, White E, Wolk A, Woods MO, Wu AH, Campbell PT, Casey G, Conti DV, Gunter MJ, Kundaje A, Lewinger JP, Moreno V, Newcomb PA, Pardamean B, Thomas DC, Tsilidis KK, Peters U, Gauderman WJ, Hsu L, Chang-Claude J.
J Natl Cancer Inst. 2022 May 05. PMID: 35512400
Jordahl KM, Shcherbina A, Kim AE, Su YR, Lin Y, Wang J, Qu C, Albanes D, Arndt V, Baurley JW, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Budiarto A, Campbell PT, Carreras-Torres R, Casey G, Cenggoro TW, Chan AT, Conti DV, Dampier CH, Devall MA, Díez-Obrero V, Dimou N, Drew DA, Figueiredo JC, Gallinger S, Giles GG, Gruber SB, Gsur A, Gunter MJ, Hampel H, Harlid S, Harrison TA, Hidaka A, Hoffmeister M, Huyghe JR, Jenkins MA, Joshi AD, Keku TO, Larsson SC, Le Marchand L, Lewinger JP, Li L, Mahesworo B, Moreno V, Morrison JL, Murphy N, Nan H, Nassir R, Newcomb PA, Obón-Santacana M, Ogino S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Peoples AR, Pharoah PDP, Platz EA, Potter JD, Prentice RL, Rennert G, Ruiz-Narvaez E, Sakoda LC, Scacheri PC, Schmit SL, Schoen RE, Slattery ML, Stern MC, Tangen CM, Thibodeau SN, Thomas DC, Tian Y, Tsilidis KK, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Vodicka P, White E, Wolk A, Woods MO, Wu AH, Zemlianskaia N, Chang-Claude J, Gauderman WJ, Hsu L, Kundaje A, Peters U.
Cancer Epidemiol Biomarkers Prev. 2022 May 04. 31(5):1077-1089. PMID: 35438744
Yuan C, Joh HK, Wang QL, Zhang Y, Smith-Warner SA, Wang M, Song M, Cao Y, Zhang X, Zoltick ES, Hur J, Chan AT, Meyerhardt JA, Ogino S, Ng K, Giovannucci EL, Wu K.
Am J Clin Nutr. 2022 Apr 25. PMID: 35470384
Elomaa H, Ahtiainen M, Väyrynen SA, Ogino S, Nowak JA, Friman M, Helminen O, Wirta EV, Seppälä TT, Böhm J, Mäkinen MJ, Mecklin JP, Kuopio T, Väyrynen JP.
Br J Cancer. 2022 Apr 21. PMID: 35449453
Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago EK, Amitay EL, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Drew DA, Figueiredo JC, French AJ, Gallinger S, Giannakis M, Giles GG, Gunter MJ, Hoffmeister M, Hsu L, Jenkins MA, Lin Y, Moreno V, Murphy N, Newcomb PA, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Potter JD, Song M, Steinfelder RS, Sun W, Thibodeau SN, Toland AE, Ugai T, Um CY, Woods MO, Phipps AI, Harrison T, Peters U.
Int J Cancer. 2022 Apr 05. PMID: 35383926
Li R, Ugai T, Xu L, Zucker D, Ogino S, Wang M.
Cancers (Basel). 2022 Apr 02. 14(7). PMID: 35406583
Cavalleri T, Greco L, Rubbino F, Hamada T, Quaranta M, Grizzi F, Sauta E, Craviotto V, Bossi P, Vetrano S, Rimassa L, Torri V, Bellazzi R, Mantovani A, Ogino S, Malesci A, Laghi L.
J Pathol Clin Res. 2022 Mar 23. PMID: 35318822
Akimoto N, Väyrynen JP, Zhao M, Ugai T, Fujiyoshi K, Borowsky J, Zhong R, Haruki K, Arima K, Lau MC, Kishikawa J, Twombly TS, Takashima Y, Song M, Zhang X, Wu K, Chan AT, Meyerhardt JA, Giannakis M, Nowak JA, Ogino S.
Front Immunol. 2022. 13:840198. PMID: 35392092
Kim MS, Seong D, Li H, Chung SK, Park Y, Lee M, Lee SW, Yon DK, Kim JH, Lee KH, Solmi M, Dragioti E, Koyanagi A, Jacob L, Kronbichler A, Tizaoui K, Cargnin S, Terrazzino S, Hong SH, Abou Ghayda R, Radua J, Oh H, Kostev K, Ogino S, Lee IM, Giovannucci E, Barnett Y, Butler L, McDermott D, Ilie PC, Shin JI, Smith L.
Rev Med Virol. 2022 Feb 26. e2336. PMID: 35218279
December 20, 2017 – People with colorectal cancer (CRC) who drank at least four cups of coffee per day after their diagnosis had a significantly lower risk of early death—from either their cancer or any cause—than those who…
Study supports ten-year screening interval, with more frequent intervals if personal history of adenoma or family history of colorectal cancer For immediate release: Wednesday, September 18, 2013 Boston, MA— According to a large, long-term study from Harvard School…
Colorectal cancer patients with a particular gene mutation may gain several years of life if they take aspirin, according to Harvard School of Public Health (HSPH) research. Roughly 20 percent of those with colorectal cancer have the mutation,…